Published in Managed Care Law Weekly, June 12th, 2005
Study 1: Researchers have produced human immunodeficiency virus type 1 vectors with alphavirus envelope glycoproteins from stable packaging cells.
According to published research from the United States, "Alphavirus glycoproteins have broad host ranges. Human immunodeficiency virus type 1 (HIV-1) vectors pseudotyped with their glycoproteins could extend the range of tissues that can be transduced in both humans and animal models. Here, we established stable producer cell lines for HIV vectors pseudotyped with alphavirus Ross River virus (RRV) and Semliki Forest...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Law Weekly